Published on 2025.09.26 ・ Company news
We are proud to announce that Panlabs Biologics Inc. has received the Excellence Award in the Innovative Technology Application – Biotech Category at the 2025 Taipei Biotech Awards.
This recognition reflects over 50 years of dedication and persistence, built upon our core technology:
“Platform for Microbial Strain Improvement and Optimization.”
We believe:
To date, Panlabs has completed 300+ projects, served hundreds of partners, and established 30–500L scale-up and validation capabilities.
This award is not only an honor, but also a driving force that inspires us to continue innovating.
We sincerely thank our team members, partners, and supporters. Special thanks to Chiang Wan-an for presenting the award and for the encouragement—it truly means a lot to us.
We will keep moving forward!
Platform for Microbial Strain Improvement and Optimization
Our strain improvement platform integrates mutagenesis, high-throughput screening, genetic engineering, and metabolic design, further empowered by AI-assisted analysis. This enables us to rapidly extract insights from massive datasets, accelerating R&D and enhancing yield and efficiency across industries.
Honored with the 2025 Taipei Biotech Award – Innovation in Technology Award –Applied Biotechnology Division, this recognition is not only an achievement but also a new beginning.
We will continue to drive innovation with “Microbes × AI,” creating more possibilities in pharmaceuticals, skincare, food, and green processes! 
建議您使用以下瀏覽器觀看本網站，
以獲得最佳瀏覽效果。
